naltrexone has been researched along with Pregnancy in 135 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 26 (19.26) | 18.7374 |
1990's | 44 (32.59) | 18.2507 |
2000's | 25 (18.52) | 29.6817 |
2010's | 29 (21.48) | 24.3611 |
2020's | 11 (8.15) | 2.80 |
Authors | Studies |
---|---|
Ashmead, R; Bailey, E; Bickert, T; Bonny, AE; Doogan, NJ; Mack, A; Schmidt, S; Tossone, K; Zhang, P | 1 |
Alimoradi, N; Hashemi, NN; Pemathilaka, RL; Reynolds, DE | 1 |
Agius, E; Kollin, R; Lee, G; Madden, EF; Pasman, E; Resko, SM; Rodriguez, B | 1 |
Carmody, T; Cook, RR; Korthuis, PT; Levander, XA; Potter, JS; Shoptaw, S; Trivedi, MH | 1 |
Klein, C; Kwong, GPS | 1 |
Coffa, D; Snyder, H | 1 |
Caritis, SN; Venkataramanan, R | 1 |
Chin, PY; Diener, KR; Hutchinson, MR; Moldenhauer, LM; Rice, KC; Robertson, SA; Sharkey, DJ; Wahid, HH | 1 |
Brown, A; Grindlay, DJC; Harman, KE; Rogers, NK; Tasker, F | 1 |
Greenland, M; Kelty, E; Preen, D; Terplan, M | 1 |
Ahrens, K; Allen, L; Austin, A; Barnes, AJ; Burns, M; Chang, CH; Clark, S; Cole, E; Crane, D; Cunningham, P; Donohue, JM; Gordon, AJ; Idala, D; Jarlenski, MP; Junker, S; Kennedy, S; Kim, JY; Lanier, P; Mauk, R; McDuffie, MJ; Mohamoud, S; Pauly, N; Sheets, L; Talbert, J; Tang, L; Zivin, K | 1 |
Hulse, G; Kelty, E | 3 |
Griffin, BL; Stone, RH; Todd, TJ; Tran, TH; Vest, KM | 1 |
Buisman-Pijlman, FT; Hutchinson, MR; Jacobsen, JHW; Mustafa, S; Rice, KC | 1 |
Jones, CW; Terplan, M | 1 |
An, J; Chen, C; Li, X; Lu, H; Tan, R; Wang, F; Wang, J; Wu, G; Zhao, X | 1 |
Butler, F; Witt, L | 1 |
Landau, R | 1 |
Carter, G; Jones, H; Miller, M; Saia, K; Shrestha, H; Valle, E; Wachman, EM; Werler, M | 1 |
Glance, JB; Gopalan, P; Kmiec, J; Spada, M | 1 |
Katz, E; Towers, CV; Visconti, K; Weitz, B | 1 |
Bordner, KA; Carter, JM; Landin, JD; Nizhnikov, ME; Pautassi, RM; Spear, NE; Varlinskaya, EI; Werner, DF | 1 |
Bregonzio, C; de Di Nasso, EG; Gamboa, DF; Pennacchio, GE; Soaje, M; Valdez, SR | 1 |
Aranda-Fernández, PE; Chotro, MG; Gaztañaga, M | 1 |
Carvalho, B; Nathan, E; Ng, L; Paech, M; Sia, A; Sng, B | 1 |
Ling, Y; Oberdick, J; Phelps, MA; Sadee, W; Schilling, K; Yudovich, MS | 1 |
Ahmed, MI; Duleba, AJ; El Shahat, O; Ibrahim, ME; Salem, A | 1 |
Dunlop, SA; Farid, WO; Hulse, GK; McCallum, D; Tait, RJ | 1 |
Barr, GA; McPhie, AA | 1 |
Dehpour, AR; Ghazi, P; Hantoushzadeh, S; Javadi-Paydar, M; Lesani, A; Norouzi, A; Tavangar, SM; Vakilipour, R | 1 |
Méndez-Gallardo, V; Robinson, SR | 1 |
Flynn, PM; Friedmann, PD; Frisman, LK; Gordon, M; Hall, E; Hoskinson, R; Kinlock, T; Knight, K; Knudsen, HK; O'Connell, DJ; Sacks, S; Schwartz, R; Shafer, MS; Stein, LA; Welsh, WN | 1 |
Chisolm, MS; Jansson, LM; Jones, HE; Terplan, M | 2 |
Kent, PF; Youngentob, LM; Youngentob, SL | 1 |
Hulse, G; Kunøe, N; Lobmaier, P; Ngo, H | 1 |
Dunlop, SA; Farid, WO; Hulse, GK; Krstew, EV; Lawrence, AJ; Tait, RJ | 1 |
Chervenak, FA; Coverdale, JH; McCullough, LB | 1 |
Stitzer, ML | 1 |
White, J | 1 |
Waal, H | 1 |
Clark, N; Verster, A | 1 |
McLaughlin, PJ | 1 |
Hulse, G; O'Neil, G | 1 |
Andrews, ZB; Grattan, DR | 1 |
Keller, M; Nowak, R; Shayit, M; Weller, A | 1 |
Nosenko, ND; Reznikov, AG; Tarasenko, LV | 2 |
Arnold-Reed, DE; Hansson, RC; Hulse, GK; O'Neil, G | 1 |
Arnold-Reed, DE; Hulse, GK; O'Neil, G | 1 |
Esquilin, M; Gibney, GT; Hong, SS; Xia, Y; Yu, J | 1 |
Canpolat, S; Kelestimur, H; Kumru, S; Kutlu, S; Ozcan, M; Sandal, S; Yilmaz, B | 1 |
Beer, A; Huleihel, R; Izrael, M; Katz, S; Levi, Y; Rozenboim, I; Slotkin, TA; Yanai, J; Yaniv, SP | 1 |
Arthuri, MT; de Arruda Veiga, MC; Gameiro, GH; Tambeli, CH | 1 |
Holtzman, SG; Michaels, CC | 1 |
Bian, ZX; Leung, WM; Li, Z; Liu, L; Xu, HX; Zhang, XJ | 1 |
Hahn, EF | 1 |
Nikolarakis, KE; Pfeiffer, A; Pfeiffer, DG | 1 |
Christian, MS | 1 |
Asali, LA; Brown, KF | 1 |
Emmert, SE; Hartman, RD; Miller, DS; Rosella-Dampman, LM; Summy-Long, JY | 1 |
Aroyewun, OO; Barr, GA | 1 |
Gintzler, AR | 2 |
Corder, CN; Nieder, GL | 1 |
Bade, V; Haldar, J | 1 |
Brailly, S; Chanson, P; Couzinet, B; Schaison, G; Young, J | 1 |
Keshet, GI; Weinstock, M | 1 |
Cheng, PY; Soong, Y; Szeto, HH; Wu, DL | 1 |
de Costa, BR; Orlowski, M; Petrov, ES; Rice, KC; Robinson, SR; Smotherman, WP; Varlinskaya, EI | 1 |
Gallo, RV; Zhen, S | 2 |
Boylan, CB; Kehoe, P | 1 |
Ahmed, MS; Cemerikic, B; Zamah, R | 1 |
Franks, S; Gilling-Smith, C | 1 |
Amundsen, L; Binstock, W; Cox, SM; Faure, EA; Glosten, B; Hibbard, J; Ismail, M; Moawad, AH; Senal, JA; Wittels, B | 1 |
Leyendecker, G; Rabenbauer, B; Sir-Petermann, T; Waibel-Treber, S; Wildt, L | 1 |
Leyendecker, G; Waibel-Treber, S; Wildt, L | 1 |
Cheng, PY; Decena, J; McCabe, S; Soong, Y; Szeto, HH; Wu, D | 1 |
Dawson-Basoa, MB; Gintzler, AR | 1 |
Moody, CA; Robinson, SR; Smotherman, WP; Spear, LP | 1 |
Hammer, RP; Seatriz, JV | 1 |
Bull, PM; Clarke, G; Douglas, AJ; MacMillan, SJ; McGrory, BG; Neumann, I; Russell, JA; Way, SA; Wright, DM | 1 |
Leyendecker, G; Sir-Petermann, T; Waibel-Treber, S; Wildt, L | 1 |
Bendotti, C; Bertelli, A; Di Giulio, AM; Germani, E; Gorio, A; Mantegazza, P | 1 |
Caba, M; Krehbiel, D; Lévy, F; Poindron, P; Romeyer, A; Vénier, G | 1 |
Cohen, E; Keshet, G; Shavit, Y; Weinstock, M | 1 |
Dawson-Basoa, ME; Gintzler, AR | 1 |
Luján Estrada, M; Medina Jiménez, M; Rodríguez, R | 1 |
Dawson-Basoa, M; Gintzler, AR | 2 |
Caggiula, AR; Di Pirro, JM; Kristal, MB; Robinson-Vanderwerf, TM | 1 |
Lang, CM; McLaughlin, PJ; Tobias, SW; Zagon, IS | 2 |
Citino, SB; Heard, DJ; Schumacher, J; Young, L | 1 |
Bots, RS; Evers, JL; Roozenburg, BJ; van Dessel, HJ | 1 |
Hurst, WJ; McLaughlin, PJ; Zagon, IS | 2 |
McLaughlin, PJ; Tobias, SW; Zagon, IS | 1 |
Bicknell, RJ; Dye, S; Leng, G | 1 |
Hytrek, SD; McLaughlin, PJ; Tobias, SW; Zagon, IS | 1 |
Barr, GA; Hamowy, AS; Hutchings, DE; Liu, PY; Wang, S; Zmitrovich, A | 1 |
McLaughlin, PJ; Wu, Y; Zagon, IS | 1 |
Barr, GA; Jones, KL | 1 |
Armant, DR; Hannigan, JH | 1 |
Albuquerque, EX; Alkondon, M; Almeida, LE; Fawcett, WP; Pereira, EF; Randall, WR | 1 |
Haddad, GG; Xia, Y; Zhang, J | 1 |
Bailey, SL; Faut-Callahan, M; Graves, J; Paice, JA; Pellegrini, JE; Shott, S | 1 |
Brewer, C; Hulse, GK; O'Neill, G; Pereira, C | 1 |
Hulse, GK; O'Neill, G | 1 |
Harry, GJ; Rosecrans, JA | 1 |
Robinson, SR; Smotherman, WP | 1 |
Agbas, A; Ahmed, MS; Cemerikic, B; Cheng, J | 1 |
Kehoe, P; Shoemaker, W | 1 |
Abboud, TK; Afrasiabi, A; Davidson, J; Khoo, N; Reyes, A; Steffens, Z; Zhu, J | 1 |
Hammer, RP; Ricalde, AA | 1 |
Abboud, TK; Afrasiabi, A; Chai, M; Lee, K; Mantilla, M; Reyes, A; Steffens, Z; Zhu, J | 1 |
Hayden, T; Orth, JM; Ward, IL; Ward, OB; Weisz, J | 1 |
Keverne, EB; Remfry, CJ; Rosser, AE | 1 |
Kosenkova, NS; Poshivalov, VP | 1 |
Ahmed, MS; Quarles, C; Schoof, T; Zhou, DH | 1 |
Schuster, CR; Snyder, M | 1 |
Gintzler, AR; Portoghese, PS; Sander, HW | 1 |
Faris, PL; Komisaruk, BR; Mayer, AD; Rosenblatt, JS | 1 |
Zagon, IS | 1 |
Evans, RG; Olley, JE | 1 |
Ammassari-Teule, M; Castellano, C; D'Amato, FR; Oliverio, A | 1 |
Plendl, J; Reinöhl-Kompa, S; Schmahl, WG | 1 |
Gintzler, AR; Sander, HW | 1 |
Baker, TB; Dahl, JL; Silva, BW; Tiffany, ST | 1 |
Monaghan, EP; Ward, IL; Ward, OB | 1 |
Abbott, P; Kristal, MB; Thompson, AC | 1 |
Grishkat, HL; Kristal, MB; Thompson, AC | 1 |
14 review(s) available for naltrexone and Pregnancy
Article | Year |
---|---|
Opioid Use Disorder: Medical Treatment Options.
Topics: Analgesics, Opioid; Buprenorphine; Chronic Disease; Evidence-Based Medicine; Female; Humans; Male; Mass Screening; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy | 2019 |
What's new in atopic eczema? An analysis of systematic reviews published in 2018. Part 1: prevention and topical therapies.
Topics: Administration, Topical; Animals; Breast Feeding; Complementary Therapies; Dermatitis, Atopic; Eczema; Fatty Acids; Female; Humans; Hypothalamo-Hypophyseal System; Infant Formula; Infant, Newborn; Janus Kinase Inhibitors; Lacticaseibacillus rhamnosus; Milk; Naltrexone; Narcotic Antagonists; Pituitary-Adrenal System; Pregnancy; Probiotics; Skin Lightening Preparations; Steroids; Vitamin D; Whey Proteins | 2020 |
Pharmacotherapies for the Treatment of Alcohol Use Disorders During Pregnancy: Time to Reconsider?
Topics: Acamprosate; Alcohol Abstinence; Alcohol Deterrents; Alcoholism; Animals; Comorbidity; Disulfiram; Female; Fetal Alcohol Spectrum Disorders; Humans; Naltrexone; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Substance Withdrawal Syndrome | 2021 |
Use of Medications for Treatment of Opioid Use Disorder Among US Medicaid Enrollees in 11 States, 2014-2018.
Topics: Adolescent; Adult; Analgesics, Opioid; Buprenorphine; Child; Cross-Sectional Studies; Female; Humans; Male; Medicaid; Methadone; Middle Aged; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; United States; Young Adult | 2021 |
A Retrospective Cohort Study of Obstetric Outcomes in Opioid-Dependent Women Treated with Implant Naltrexone, Oral Methadone or Sublingual Buprenorphine, and Non-Dependent Controls.
Topics: Administration, Oral; Administration, Sublingual; Buprenorphine; Drug Implants; Female; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Retrospective Studies | 2017 |
Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
Topics: Analgesics, Opioid; Animals; Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Naltrexone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Treatment Outcome | 2017 |
Post-cesarean delivery pain. Management of the opioid-dependent patient before, during and after cesarean delivery.
Topics: Analgesia, Patient-Controlled; Buprenorphine; Cesarean Section; Female; Humans; Methadone; Naltrexone; Opioid-Related Disorders; Pain, Postoperative; Pregnancy; Pregnancy Complications | 2019 |
Consideration of opioid agonist treatment in a pregnant adolescent: A case report and literature review.
Topics: Adolescent; Ambulatory Care; Analgesics, Opioid; Buprenorphine; Child, Foster; Female; Humans; Lost to Follow-Up; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications; Pregnancy in Adolescence | 2020 |
Naltrexone in the treatment of opioid-dependent pregnant women: the case for a considered and measured approach to research.
Topics: Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Risk Assessment; Risk Factors; Treatment Outcome | 2013 |
Injectable and implantable sustained release naltrexone in the treatment of opioid addiction.
Topics: Delayed-Action Preparations; Drug Implants; Female; Heroin Dependence; Humans; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Prisoners; Time Factors | 2014 |
Advances in induction of ovulation.
Topics: Buserelin; Clinical Trials as Topic; Clomiphene; Drug Administration Schedule; Drug Resistance; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins; Growth Hormone; Humans; Hypogonadism; Naltrexone; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Outcome | 1994 |
Endogenous opioids and prenatal determinants of neuroplasticity.
Topics: Animals; Animals, Newborn; Embryonic and Fetal Development; Endorphins; Female; Humans; Naltrexone; Neuronal Plasticity; Pregnancy; Prenatal Diagnosis | 1997 |
Alcohol in pregnancy and neonatal outcome.
Topics: Abortion, Spontaneous; Alcohol Drinking; Birth Weight; Developmental Disabilities; Female; Fetal Alcohol Spectrum Disorders; Gestational Age; Humans; Maternal Behavior; Naltrexone; Pregnancy; Pregnancy Outcome | 2000 |
Opioids and development: new lessons from old problems.
Topics: Animals; Brain; Child Behavior; Child Development; Dose-Response Relationship, Drug; Female; Fetus; Humans; Naltrexone; Narcotics; Opioid-Related Disorders; Pregnancy; Rats; Receptors, Opioid; Substance Withdrawal Syndrome | 1985 |
8 trial(s) available for naltrexone and Pregnancy
Article | Year |
---|---|
A gender-based secondary analysis of the ADAPT-2 combination naltrexone and bupropion treatment for methamphetamine use disorder trial.
Topics: Adult; Bupropion; Central Nervous System Stimulants; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Methamphetamine; Naltrexone; Pregnancy | 2023 |
Methylnaltrexone to prevent intrathecal morphine-induced pruritus after Caesarean delivery: a multicentre, randomized clinical trial.
Topics: Adult; Analgesia, Obstetrical; Analgesics, Opioid; Anesthesia, Spinal; Australia; Cesarean Section; Female; Humans; Middle Aged; Morphine; Naltrexone; Narcotic Antagonists; Postoperative Complications; Pregnancy; Pruritus; Quaternary Ammonium Compounds; Singapore; Treatment Outcome; United States; Young Adult | 2015 |
Even after priming with ovarian steroids or pulsatile gonadotropin-releasing hormone administration, naltrexone is unable to induce ovulation in women with functional hypothalamic amenorrhea.
Topics: Adult; Amenorrhea; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Hypothalamus; Luteinizing Hormone; Naltrexone; Ovulation Induction; Pregnancy; Progesterone; Statistics, Nonparametric | 1995 |
Opioid antagonist adjuncts to epidural morphine for postcesarean analgesia: maternal outcomes.
Topics: Adult; Analgesia, Epidural; Analgesia, Obstetrical; Butorphanol; Cesarean Section; Female; Humans; Morphine; Nalbuphine; Naltrexone; Narcotic Antagonists; Pain, Postoperative; Pregnancy; Prospective Studies | 1993 |
Successful induction of ovulation in normogonadotrophic clomiphene resistant anovulatory women by combined naltrexone and clomiphene citrate treatment.
Topics: Administration, Oral; Adult; Anovulation; Clomiphene; Drug Resistance; Drug Therapy, Combination; Female; Fertility Agents, Female; Gonadotropins; Humans; Naltrexone; Narcotic Antagonists; Ovulation Induction; Pregnancy; Pregnancy Rate | 1997 |
The impact of nalmefene on side effects due to intrathecal morphine at cesarean section.
Topics: Adult; Analgesia, Epidural; Analgesics, Opioid; Cesarean Section; Double-Blind Method; Female; Humans; Morphine; Naltrexone; Narcotic Antagonists; Pain, Postoperative; Postoperative Complications; Postoperative Nausea and Vomiting; Pregnancy; Pruritus; Statistics, Nonparametric; Survival Analysis; Time Factors | 2001 |
Prophylactic oral naltrexone with epidural morphine: effect on adverse reactions and ventilatory responses to carbon dioxide.
Topics: Administration, Oral; Adult; Analgesia, Epidural; Anesthesia, Obstetrical; Carbon Dioxide; Cesarean Section; Double-Blind Method; Female; Humans; Morphine; Naltrexone; Pain, Postoperative; Pregnancy; Prospective Studies; Randomized Controlled Trials as Topic; Respiration Disorders | 1990 |
Prophylactic oral naltrexone with intrathecal morphine for cesarean section: effects on adverse reactions and analgesia.
Topics: Administration, Oral; Adult; Cesarean Section; Double-Blind Method; Female; Humans; Injections, Spinal; Morphine; Naltrexone; Nausea; Pain, Postoperative; Pregnancy; Pruritus; Randomized Controlled Trials as Topic; Sleep | 1990 |
113 other study(ies) available for naltrexone and Pregnancy
Article | Year |
---|---|
Examining differences in retention on medication for opioid use disorder: An analysis of Ohio Medicaid data.
Topics: Adolescent; Analgesics, Opioid; Buprenorphine; Female; Humans; Medicaid; Methadone; Naltrexone; Ohio; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Quality of Life; United States; Young Adult | 2022 |
Transport of Maternally Administered Pharmaceutical Agents Across the Placental Barrier In Vitro.
Topics: Coculture Techniques; Endothelial Cells; Female; Humans; Naltrexone; Pharmaceutical Preparations; Placenta; Pregnancy | 2022 |
Attitudes toward Medication for Opioid Use Disorder among Substance Use Treatment Providers.
Topics: Analgesics, Opioid; Buprenorphine; Child; Female; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Treatment Outcome | 2022 |
Deslorelin and naltrexone stimulate follicular development in mares during autumn transition and early anestrus.
Topics: Anestrus; Animals; Female; Horses; Naltrexone; Ovulation; Pregnancy; Triptorelin Pamoate | 2019 |
Naltrexone use in pregnancy: a time for change.
Topics: Female; Humans; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Pregnancy | 2020 |
Toll-Like Receptor-4 Antagonist (+)-Naltrexone Protects Against Carbamyl-Platelet Activating Factor (cPAF)-Induced Preterm Labor in Mice.
Topics: Animals; Female; Mice; Mice, Inbred BALB C; Naltrexone; Narcotic Antagonists; Obstetric Labor, Premature; Platelet Activating Factor; Pregnancy; Toll-Like Receptor 4 | 2020 |
A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates.
Topics: Adult; Australia; Buprenorphine; Drug Administration Routes; Female; Humans; Incidence; Infant, Newborn; Male; Methadone; Naltrexone; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Prenatal Exposure Delayed Effects; Retrospective Studies | 2017 |
Antagonising TLR4-TRIF signalling before or after a low-dose alcohol binge during adolescence prevents alcohol drinking but not seeking behaviour in adulthood.
Topics: Adaptor Proteins, Vesicular Transport; Animals; Animals, Newborn; Binge Drinking; Central Nervous System Depressants; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Ethanol; Female; gamma-Aminobutyric Acid; Mice; Mice, Inbred BALB C; Naltrexone; Pregnancy; RNA, Messenger; Signal Transduction; Toll-Like Receptor 4 | 2018 |
A retrospective cohort study of the health of children prenatally exposed to methadone, buprenorphine or naltrexone compared with non-exposed control children.
Topics: Adult; Buprenorphine; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Longitudinal Studies; Male; Methadone; Naltrexone; Pregnancy; Prenatal Exposure Delayed Effects; Retrospective Studies; Western Australia | 2017 |
Pregnancy and Naltrexone Pharmacotherapy.
Topics: Adult; Delivery, Obstetric; Female; Humans; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Pain, Postoperative; Pregnancy; Pregnancy Complications | 2018 |
Short term exposure to oxycodone alters the survival, proliferation and differentiation of rat embryonic neural stem cell in vitro.
Topics: Analgesics, Opioid; Animals; Apoptosis; Cell Differentiation; Cell Proliferation; Cell Survival; Embryonic Stem Cells; Female; Morphine; Naltrexone; Neural Stem Cells; Oxycodone; Pregnancy; Rats; Rats, Sprague-Dawley | 2018 |
Prescription Drug and Alcohol Use Disorders: Opioid Use Disorder.
Topics: Analgesics, Opioid; Buprenorphine; Female; Humans; Methadone; Naltrexone; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy | 2019 |
Naltrexone Treatment for Pregnant Women With Opioid Use Disorder Compared With Matched Buprenorphine Control Subjects.
Topics: Adult; Analgesics, Opioid; Buprenorphine; Female; Humans; Infant, Newborn; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Pilot Projects; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Retrospective Studies; Treatment Outcome | 2019 |
Use of naltrexone in treating opioid use disorder in pregnancy.
Topics: Abortion, Spontaneous; Adult; Analgesics, Opioid; Buprenorphine; Case-Control Studies; Female; Humans; Infant, Newborn; Methadone; Naltrexone; Narcotic Antagonists; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Prospective Studies; Stillbirth; Young Adult | 2020 |
Brief prenatal ethanol exposure alters behavioral sensitivity to the kappa opioid receptor agonist (U62,066E) and antagonist (Nor-BNI) and reduces kappa opioid receptor expression.
Topics: Alcohol Drinking; Animals; Brain Chemistry; Conditioning, Psychological; Ethanol; Female; Gene Expression; Male; Naltrexone; Pregnancy; Prenatal Exposure Delayed Effects; Pyrrolidines; Rats, Sprague-Dawley; Receptors, Opioid, kappa | 2014 |
Opioid modulation of prolactin secretion induced by stress during late pregnancy. Role of ovarian steroids.
Topics: Analgesics, Opioid; Animals; Estradiol; Female; Mifepristone; Naloxone; Naltrexone; Narcotic Antagonists; Ovary; Pregnancy; Progesterone; Prolactin; Rats; Rats, Wistar; Steroids; Tamoxifen | 2014 |
Prenatal exposure to vanilla or alcohol induces crawling after these odors in the neonate rat: The role of mu and kappa opioid receptor systems.
Topics: Analysis of Variance; Animals; Animals, Newborn; Drug-Seeking Behavior; Ethanol; Female; Locomotion; Maternal Exposure; Naloxone; Naltrexone; Odorants; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Vanilla | 2015 |
Preferential Delivery of an Opioid Antagonist to the Fetal Brain in Pregnant Mice.
Topics: Animals; Behavior, Animal; Brain; Dose-Response Relationship, Drug; Female; Mice, Inbred C57BL; Morphine; Naltrexone; Narcotic Antagonists; Placenta; Pregnancy; Substance Withdrawal Syndrome; Tissue Distribution | 2016 |
Naltrexone treatment in clomiphene resistant women with polycystic ovary syndrome.
Topics: Adolescent; Adult; Analgesics, Opioid; Body Mass Index; Clomiphene; Drug Resistance; Estrogen Antagonists; Female; Humans; Infertility, Female; Luteinizing Hormone; Naltrexone; Narcotic Antagonists; Polycystic Ovary Syndrome; Pregnancy; Pregnancy Rate | 2008 |
Minor pathological changes are induced by naltrexone-poly(DL-lactide) implants in pregnant rats.
Topics: Animals; Biocompatible Materials; Birefringence; Female; Foreign-Body Reaction; Implants, Experimental; Inflammation; Male; Naltrexone; Polyesters; Pregnancy; Rats; Rats, Sprague-Dawley; Skin | 2009 |
Regional Fos expression induced by morphine withdrawal in the 7-day-old rat.
Topics: Analysis of Variance; Animals; Animals, Newborn; Cell Count; Female; Immunohistochemistry; Locus Coeruleus; Male; Morphine; Morphine Dependence; Naltrexone; Narcotic Antagonists; Narcotics; Nucleus Accumbens; Periaqueductal Gray; Pregnancy; Proto-Oncogene Proteins c-fos; Rats; Rats, Long-Evans; Spinal Cord; Substance Withdrawal Syndrome | 2009 |
Evaluation of the tocolytic effect of morphine in a mouse model of lipopolysaccharide-induced preterm delivery: the role of nitric oxide.
Topics: Animals; Female; Lipopolysaccharides; Male; Mice; Morphine; Naltrexone; NG-Nitroarginine Methyl Ester; Nitric Oxide; Obstetric Labor, Premature; Placenta; Pregnancy; Tocolytic Agents | 2009 |
Opioid mediation of amniotic fluid effects on chemosensory responsiveness in the neonatal rat.
Topics: Administration, Oral; Amniotic Fluid; Analysis of Variance; Animals; Animals, Newborn; Animals, Suckling; Behavior, Animal; Female; Male; Milk; Motor Activity; Naltrexone; Narcotic Antagonists; Opioid Peptides; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Stimulation, Chemical | 2010 |
Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions.
Topics: Adult; Buprenorphine; Crime; Criminal Law; Data Collection; Female; Humans; Male; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Pregnancy; Pregnancy Complications; Prisons; Substance-Related Disorders; Young Adult | 2012 |
Gestational naltrexone ameliorates fetal ethanol exposures enhancing effect on the postnatal behavioral and neural response to ethanol.
Topics: Animals; Animals, Newborn; Behavior, Animal; Ethanol; Female; Maternal Exposure; Maternal-Fetal Exchange; Naltrexone; Neuroprotective Agents; Odorants; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Smell | 2012 |
Maternally administered sustained-release naltrexone in rats affects offspring neurochemistry and behaviour in adulthood.
Topics: Animals; Behavior, Animal; Brain; Delayed-Action Preparations; Dynorphins; Enkephalins; Female; Gene Expression; Male; Morphine; Motor Activity; Naltrexone; Narcotic Antagonists; Narcotics; Neostriatum; Pregnancy; Prenatal Exposure Delayed Effects; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Self Administration | 2012 |
An ethical framework for conducting research on pregnant, opioid-dependent women.
Topics: Ethics, Medical; Female; Humans; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Research Design | 2013 |
Dual dilemma-should naltrexone be used in the treatment of opioid-dependent pregnant women?
Topics: Buprenorphine; Female; Humans; Infant, Newborn; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Neonatal Abstinence Syndrome; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Risk Assessment; Treatment Outcome | 2013 |
Blocking endogenous opioids during development--do we understand the consequences?
Topics: Animals; Brain; Buprenorphine; Female; Fetal Development; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Treatment Outcome | 2013 |
Is sustained release natrexone an option for heroin-dependent pregnant women?
Topics: Animals; Female; Fetus; Heroin Dependence; Humans; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Rats; Research Design | 2013 |
Double trouble-pregnancy and antagonist treatment in opioid dependence; two contentious issues needing further consideration and research.
Topics: Buprenorphine; Female; Humans; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Practice Guidelines as Topic; Pregnancy; Pregnancy Complications; Randomized Controlled Trials as Topic; Research Design; Substance Withdrawal Syndrome | 2013 |
Naltrexone in the treatment of opioid-dependent pregnant women: common ground.
Topics: Animals; Brain; Buprenorphine; Ethics, Medical; Female; Fetal Development; Heroin Dependence; Humans; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Pregnancy; Pregnancy Complications; Research Design | 2013 |
Exposure to the opioid antagonist naltrexone throughout gestation alters postnatal heart development.
Topics: Aging; Animals; Body Weight; DNA; Female; Gestational Age; Heart; Litter Size; Male; Myocardium; Naltrexone; Narcotic Antagonists; Opioid Peptides; Organ Size; Pregnancy; Prenatal Exposure Delayed Effects; Proteins; Rats; Rats, Sprague-Dawley; RNA | 2002 |
Using naltrexone implants in the management of the pregnant heroin user.
Topics: Adult; Drug Implants; Female; Heroin Dependence; Humans; Infant, Newborn; Male; Naltrexone; Narcotic Antagonists; Pregnancy; Pregnancy Complications; Pregnancy Outcome | 2002 |
Opioid receptor subtypes involved in the regulation of prolactin secretion during pregnancy and lactation.
Topics: Animals; Female; Injections, Intraventricular; Lactation; Naltrexone; Narcotic Antagonists; Pituitary Gland; Pregnancy; Pregnancy, Animal; Prolactin; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 2003 |
Establishment of a preference by the newborn lamb for its mother: the role of opioids.
Topics: Animals; Animals, Newborn; Choice Behavior; Female; Maternal Exposure; Naltrexone; Narcotic Antagonists; Narcotics; Object Attachment; Pregnancy; Receptors, Opioid; Sheep | 2003 |
Participation of endogenous opioids in pathogenesis of early neuroendocrine manifestations of prenatal stress syndrome.
Topics: Animals; Dopamine; Female; Hypothalamus; Male; Naltrexone; Narcotic Antagonists; Neurosecretory Systems; Norepinephrine; Opioid Peptides; Pregnancy; Rats; Rats, Wistar; Sex Characteristics; Stress, Psychological; Syndrome; Testosterone | 2003 |
Naltrexone implant and blood naltrexone levels over pregnancy.
Topics: Adult; Drug Implants; Female; Heroin Dependence; Humans; Naltrexone; Narcotic Antagonists; Pregnancy; Pregnancy Complications | 2003 |
Methadone maintenance vs. implantable naltrexone treatment in the pregnant heroin user.
Topics: Australia; Drug Implants; Female; Heroin Dependence; Humans; Methadone; Naltrexone; Narcotic Antagonists; Narcotics; Pregnancy; Pregnancy Complications; Pregnancy Outcome | 2004 |
Effect of protein kinases on lactate dehydrogenase activity in cortical neurons during hypoxia.
Topics: Animals; Cell Hypoxia; Cells, Cultured; Cerebral Cortex; Cyclic AMP; Embryo, Mammalian; Enkephalin, Leucine-2-Alanine; Enzyme Activators; Enzyme Inhibitors; Female; Hypoxia; L-Lactate Dehydrogenase; Naltrexone; Neurons; Pregnancy; Protein Kinases; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Time Factors | 2004 |
Mu opioid modulation of oxytocin secretion in late pregnant and parturient rats. Involvement of noradrenergic neurotransmission.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Animals; Cinnamates; Enzyme-Linked Immunosorbent Assay; Estrogens; Female; Methoxyhydroxyphenylglycol; Morphine Derivatives; Naltrexone; Narcotic Antagonists; Narcotics; Norepinephrine; Oxytocin; Paraventricular Hypothalamic Nucleus; Pregnancy; Progesterone; Rats; Rats, Wistar; Receptors, Opioid, kappa; Receptors, Opioid, mu; Supraoptic Nucleus | 2004 |
Convergent effects on cell signaling mechanisms mediate the actions of different neurobehavioral teratogens: alterations in cholinergic regulation of protein kinase C in chick and avian models.
Topics: Animals; Cholinergic Fibers; Ducks; Female; Heroin; Imprinting, Psychological; Mice; Naltrexone; Pregnancy; Prenatal Exposure Delayed Effects; Signal Transduction; Teratogens | 2004 |
Peripheral effect of a kappa opioid receptor antagonist on nociception evoked by formalin injected in TMJ of pregnant rats.
Topics: Animals; Female; Formaldehyde; Naltrexone; Pain; Pregnancy; Pregnancy, Animal; Rats; Rats, Wistar; Receptors, Opioid, kappa; Temporomandibular Joint | 2005 |
Opioids are responsible for neurochemical feminization of the brain in prenatally stressed male rats.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; Animals; Aromatase; Brain Chemistry; Catecholamines; Chromatography, Thin Layer; Dopamine; Female; Feminization; Hypothalamus; Male; Naltrexone; Narcotic Antagonists; Norepinephrine; Opioid Peptides; Pregnancy; Prenatal Exposure Delayed Effects; Preoptic Area; Rats; Sex Characteristics; Spectrometry, Fluorescence; Stress, Psychological; Testosterone | 2005 |
Enhanced sensitivity to naltrexone-induced drinking suppression of fluid intake and sucrose consumption in maternally separated rats.
Topics: Animals; Brain; Drinking; Female; Food Preferences; Male; Models, Animal; Naltrexone; Narcotic Antagonists; Opioid Peptides; Pregnancy; Rats; Rats, Long-Evans; Reward; Sex Characteristics; Solutions; Stress, Psychological; Substance-Related Disorders; Sucrose | 2007 |
The analgesic effect of paeoniflorin on neonatal maternal separation-induced visceral hyperalgesia in rats.
Topics: Adrenergic alpha-Antagonists; alpha-Methyltyrosine; Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Benzoates; Bridged-Ring Compounds; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Interactions; Enzyme Inhibitors; Female; Glucosides; Hyperalgesia; Male; Maternal Deprivation; Monoterpenes; Naltrexone; Narcotic Antagonists; Pain Measurement; Pain Threshold; Pregnancy; Rats; Rats, Sprague-Dawley; Yohimbine | 2008 |
Chronic naloxone increases opiate binding in SHR and WKY rats.
Topics: Aging; Animals; Blood Pressure; Brain; Female; Kinetics; Male; Naloxone; Naltrexone; Narcotics; Pregnancy; Prenatal Exposure Delayed Effects; Radioimmunoassay; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Opioid | 1984 |
Chronic blockade of opiate receptors: influence on reproduction and body weight in female rats.
Topics: Animals; Body Weight; Estrus; Female; Luteinizing Hormone; Naloxone; Naltrexone; Pregnancy; Rats; Rats, Inbred Strains; Receptors, Opioid; Reproduction | 1984 |
Reproductive toxicity and teratology evaluations of naltrexone.
Topics: Animals; Body Weight; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Estrus; Female; Fertility; Fetus; Humans; Male; Maternal-Fetal Exchange; Naloxone; Naltrexone; Pregnancy; Rabbits; Rats; Reproduction; Sex Factors; Sexual Behavior, Animal; Teratogens | 1984 |
Naloxone protein binding in adult and foetal plasma.
Topics: Adult; Blood Proteins; Female; Fetal Blood; Humans; Male; Naloxone; Naltrexone; Pregnancy; Protein Binding; Serum Albumin | 1984 |
A functional role for opioid peptides in the differential secretion of vasopressin and oxytocin.
Topics: Animals; Arginine Vasopressin; Dehydration; Endorphins; Female; Hemorrhage; Hypothalamo-Hypophyseal System; Lactation; Male; Naltrexone; Oxytocin; Pregnancy; Rats; Rats, Inbred Strains | 1984 |
Effects of chronic antenatal and postnatal administration of narcotics on naloxone-induced anorexia in preweanling rats.
Topics: Aging; Animals; Animals, Suckling; Body Weight; Drug Interactions; Feeding Behavior; Female; Motor Activity; Naloxone; Naltrexone; Narcotics; Pregnancy; Prenatal Exposure Delayed Effects; Rats | 1983 |
Activation of opioid-containing systems during gestation.
Topics: Animals; Endorphins; Female; Labor, Obstetric; Naltrexone; Pain; Pregnancy; Pregnancy, Animal; Rats; Sensory Thresholds | 1982 |
Effects of opiate antagonists on early pregnancy and pseudopregnancy in mice.
Topics: Animals; Bromocriptine; Female; Mice; Naltrexone; Narcotic Antagonists; Pregnancy; Pregnancy, Animal; Pseudopregnancy | 1982 |
Involvement of opioid peptides in the inhibition of oxytocin release by heat stress in lactating mice.
Topics: Animals; Endorphins; Female; Lactation; Mice; Naltrexone; Oxytocin; Pregnancy; Stress, Physiological | 1981 |
Endorphin-mediated increases in pain threshold during pregnancy.
Topics: Animals; Dose-Response Relationship, Drug; Endorphins; Female; Naltrexone; Pain; Pregnancy; Pregnancy, Animal; Rats; Time Factors | 1980 |
Maternal naltrexone prevents morphological and behavioral alterations induced in rats by prenatal stress.
Topics: Animals; Choice Behavior; Female; Infusion Pumps, Implantable; Male; Maze Learning; Naltrexone; Narcotic Antagonists; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Saccharin; Stress, Physiological | 1995 |
Effects of the delta-opioid agonist, [D-Pen2,D-Pen5]-enkephalin, on fetal lamb EEG.
Topics: Analgesics; Animals; Dose-Response Relationship, Drug; Electroencephalography; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Female; Fetus; Injections, Intraventricular; Naltrexone; Narcotic Antagonists; Pregnancy; Receptors, Opioid, delta; Sheep | 1994 |
Central administration of the endopeptidase 24.15 inhibitor cFP-AAF-pAB suggests dynorphin as the endogenous ligand underlying behavioral effects of milk in the fetal rat.
Topics: Amino Acid Sequence; Animals; Behavior, Animal; Cisterna Magna; Dynorphins; Female; Fetus; Injections; Ligands; Metalloendopeptidases; Milk; Molecular Sequence Data; Naltrexone; Narcotic Antagonists; Oligopeptides; Physical Stimulation; Pregnancy; Rats; Rats, Sprague-Dawley; Somatostatin | 1994 |
Lack of catecholamine involvement in the increased luteinizing hormone release due to blockade of kappa-opioid receptors in the medial basal hypothalamus during midpregnancy in the rat.
Topics: Animals; Dopamine; Female; Hypothalamus, Middle; Luteinizing Hormone; Naltrexone; Norepinephrine; Perfusion; Pregnancy; Pregnancy, Animal; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Secretory Rate | 1994 |
Behavioral effects of kappa-opioid-receptor stimulation on neonatal rats.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Animals, Newborn; Arousal; Behavior, Animal; Body Temperature Regulation; Brain; Dose-Response Relationship, Drug; Female; Male; Motor Activity; Naltrexone; Pain Threshold; Pregnancy; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Social Isolation; Vocalization, Animal | 1994 |
Opioids regulation of human chorionic gonadotropin release from trophoblast tissue is mediated by gonadotropin releasing hormone.
Topics: Chorionic Gonadotropin; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Female; Gonadotropin-Releasing Hormone; Humans; In Vitro Techniques; Naltrexone; Narcotics; Pregnancy; Receptors, Opioid, kappa; Trophoblasts | 1994 |
Opiate antagonist treatment of ovarian failure.
Topics: Adolescent; Adult; Amenorrhea; Blood Glucose; Endorphins; Female; Follicle Stimulating Hormone; Glucose Tolerance Test; Humans; Hypothalamus; Insulin; Insulin Resistance; Luteinizing Hormone; Middle Aged; Naltrexone; Ovarian Diseases; Pregnancy | 1993 |
Pulsatile administration of gonadotrophin releasing hormone and oral administration of naltrexone in hypothalamic amenorrhoea.
Topics: Amenorrhea; Female; Gonadotropin-Releasing Hormone; Humans; Hypothalamic Diseases; Infertility, Female; Naltrexone; Ovulation; Periodicity; Pregnancy | 1993 |
Opioid-induced stimulation of fetal respiratory activity by [D-Ala2]deltorphin I.
Topics: Animals; Dose-Response Relationship, Drug; Electromyography; Female; Fetus; Indoles; Injections, Intraventricular; Morphinans; Naloxone; Naltrexone; Narcotic Antagonists; Oligopeptides; Pregnancy; Receptors, Opioid, delta; Respiration; Sheep | 1993 |
17-Beta-estradiol and progesterone modulate an intrinsic opioid analgesic system.
Topics: Analgesia; Animals; Drug Implants; Electroshock; Endorphins; Estradiol; Female; Naltrexone; Ovariectomy; Pain Threshold; Pregnancy; Pregnancy, Animal; Progesterone; Rats; Rats, Sprague-Dawley; Receptors, Opioid | 1993 |
Effects of dopamine and kappa opioid receptors on fetal responsiveness to perioral stimuli.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Benzazepines; Brain; Dopamine; Dose-Response Relationship, Drug; Female; Fetal Movement; Naltrexone; Pregnancy; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Opioid, kappa; Stereotyped Behavior; Sucking Behavior | 1993 |
Effects of opiates on neuronal development in the rat cerebral cortex.
Topics: Animals; Body Weight; Cerebral Cortex; Female; Male; Morphine; Naltrexone; Narcotic Antagonists; Narcotics; Neurons; Pregnancy; Rats; Rats, Sprague-Dawley; Somatosensory Cortex | 1993 |
Effects of the kappa-opioid agonist U50,488 on parturition in rats.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Female; Infusions, Intravenous; Injections, Intravenous; Labor, Obstetric; Male; Morphine; Naloxone; Naltrexone; Oxytocin; Pregnancy; Pyrrolidines; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Opioid, kappa; Uterine Contraction | 1993 |
Treatment with naltrexone in hypothalamic ovarian failure: induction of ovulation and pregnancy.
Topics: Adolescent; Adult; Amenorrhea; Female; Humans; Hypothalamic Diseases; Luteinizing Hormone; Naltrexone; Ovarian Diseases; Ovulation Induction; Pregnancy | 1993 |
Perinatal morphine treatment inhibits pruning effect and regeneration of serotoninergic pathways following neonatal 5,7-HT lesions.
Topics: 5,7-Dihydroxytryptamine; Animals; Animals, Newborn; Brain Chemistry; Cerebral Cortex; Chromatography, High Pressure Liquid; Female; Hypothalamus; Immunohistochemistry; In Situ Hybridization; Morphine; Naltrexone; Nerve Regeneration; Neural Pathways; Neuronal Plasticity; Pregnancy; Rats; Rats, Sprague-Dawley; Serotonin; Spinal Cord; Sulfur Radioisotopes | 1993 |
Naltrexone delays the onset of maternal behavior in primiparous parturient ewes.
Topics: Animals; Behavior, Animal; Dose-Response Relationship, Drug; Female; Labor, Obstetric; Maternal Behavior; Naltrexone; Pregnancy; Sheep; Time Factors | 1995 |
Prenatal naltrexone facilitates male sexual behavior in the rat.
Topics: Animals; Dose-Response Relationship, Drug; Ejaculation; Female; Male; Motor Activity; Naltrexone; Narcotic Antagonists; Pain Threshold; Posture; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Sex Differentiation; Sexual Behavior, Animal; Swimming | 1996 |
Estrogen and progesterone activate spinal kappa-opiate receptor analgesic mechanisms.
Topics: Animals; Electroshock; Estradiol; Female; Naltrexone; Narcotic Antagonists; Nociceptors; Pain Measurement; Pain Threshold; Pregnancy; Pregnancy, Animal; Progesterone; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, Opioid, mu; Spinal Cord | 1996 |
Influence of chronic prenatal and postnatal administration of naltrexone in locomotor activity induced by morphine in mice.
Topics: Amphetamine; Animals; Animals, Newborn; Animals, Suckling; Dose-Response Relationship, Drug; Drug Resistance; Female; Fetus; Hyperkinesis; Locomotion; Male; Maternal-Fetal Exchange; Mice; Mice, Inbred C57BL; Morphine; Motor Activity; Naltrexone; Narcotic Antagonists; Pregnancy; Prenatal Exposure Delayed Effects; Receptors, Opioid | 1997 |
Involvement of spinal cord delta opiate receptors in the antinociception of gestation and its hormonal simulation.
Topics: Animals; Benzylidene Compounds; Female; Humans; Injections, Spinal; Male; Naltrexone; Narcotic Antagonists; Pain; Pregnancy; Pregnancy, Animal; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Sensory Thresholds; Sex Characteristics; Spinal Cord; Time Factors | 1997 |
The analgesia-enhancing component of ingested amniotic fluid does not affect nicotine-induced antinociception in naltrexone-treated rats.
Topics: Amniotic Fluid; Analgesia; Analgesics; Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Female; Morphine; Naltrexone; Narcotic Antagonists; Nicotine; Nicotinic Agonists; Pain Measurement; Pregnancy; Rats; Reaction Time | 1997 |
Chronic exposure to the opioid antagonist naltrexone during pregnancy: maternal and offspring effects.
Topics: Animals; Body Weight; Embryonic and Fetal Development; Female; Male; Naltrexone; Narcotic Antagonists; Pregnancy; Pregnancy, Animal; Rats; Rats, Sprague-Dawley; Time Factors | 1997 |
Cardiopulmonary effects of carfentanil in dama gazelles (Gazella dama).
Topics: Analgesics, Opioid; Animals; Animals, Zoo; Antelopes; Blood Gas Analysis; Blood Pressure; Carbon Dioxide; Female; Fentanyl; Heart Rate; Immobilization; Male; Naltrexone; Narcotic Antagonists; Oximetry; Oxygen; Pregnancy; Reproducibility of Results; Respiration | 1997 |
Transplacental transfer of naltrexone in rats.
Topics: Animals; Brain; Chromatography, High Pressure Liquid; Female; Heart; Kinetics; Liver; Male; Maternal-Fetal Exchange; Myocardium; Naltrexone; Narcotic Antagonists; Placenta; Pregnancy; Rats; Rats, Sprague-Dawley | 1997 |
Opioid receptor blockade during prenatal life modifies postnatal behavioral development.
Topics: Animals; Behavior, Animal; Brain; Female; Male; Motor Activity; Naltrexone; Narcotic Antagonists; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Reflex; Weight Gain | 1997 |
Kappa-opioid restraint of oxytocin secretion: plasticity through pregnancy.
Topics: Animals; Basal Metabolism; Cholecystokinin; Female; Naloxone; Naltrexone; Oxytocin; Pregnancy; Pregnancy, Animal; Rats; Rats, Wistar; Receptors, Opioid, kappa; Receptors, Opioid, mu; Secretory Rate | 1997 |
Opioid receptor blockade throughout prenatal life confers long-term insensitivity to morphine and alters mu opioid receptors.
Topics: Analgesics, Opioid; Animals; Body Weight; Female; Male; Morphine; Naltrexone; Narcotic Antagonists; Pain; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu | 1998 |
Naltrexone is not detected in preweaning rats following transplacental exposure: implications for growth modulation.
Topics: Animals; Animals, Newborn; Chromatography, High Pressure Liquid; Female; Male; Maternal-Fetal Exchange; Naltrexone; Narcotic Antagonists; Pregnancy; Rats; Rats, Sprague-Dawley; Spectrophotometry, Ultraviolet; Weaning | 1998 |
Neonatal withdrawal following pre- and postnatal exposure to methadone in the rat.
Topics: Animals; Animals, Newborn; Behavior, Animal; Female; Humans; Infant, Newborn; Male; Methadone; Motor Activity; Naltrexone; Narcotic Antagonists; Neonatal Abstinence Syndrome; Pregnancy; Rats; Rats, Wistar; Substance Withdrawal Syndrome; Vocalization, Animal | 1998 |
Gestational and ovarian sex steroid antinociception: synergy between spinal kappa and delta opioid systems.
Topics: Animals; Benzylidene Compounds; Dose-Response Relationship, Drug; Estrogens; Female; Naltrexone; Narcotic Antagonists; Ovary; Pain Threshold; Pregnancy; Pregnancy, Animal; Progesterone; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, kappa; Spinal Cord | 1998 |
Opioid growth factor and organ development in rat and human embryos.
Topics: Animals; Brain; Brain Chemistry; DNA; Ectoderm; Embryonic and Fetal Development; Endoderm; Enkephalin, Methionine; Enkephalins; Female; Fetus; Gene Expression Regulation, Developmental; Heart; Humans; Immunohistochemistry; In Situ Hybridization; Intestines; Male; Mesoderm; Muscles; Myocardium; Naltrexone; Narcotic Antagonists; Pregnancy; Protein Precursors; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Ribs; RNA, Messenger; Skin; Tongue | 1999 |
Opiate withdrawal in the fetal rat: a behavioral profile.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Female; Fetus; Humans; Maternal-Fetal Exchange; Morphine; Motor Activity; Naltrexone; Narcotic Antagonists; Pregnancy; Rats; Substance Withdrawal Syndrome | 2000 |
The opioid antagonist naltrexone inhibits activity and alters expression of alpha7 and alpha4beta2 nicotinic receptors in hippocampal neurons: implications for smoking cessation programs.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Cells, Cultured; Electrophysiology; Female; Hippocampus; In Vitro Techniques; Naltrexone; Narcotic Antagonists; Nicotine; Nicotinic Agonists; Patch-Clamp Techniques; Pregnancy; Rats; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Receptors, Nicotinic; Smoking Cessation; Up-Regulation | 2000 |
delta-, but not mu- and kappa-, opioid receptor activation protects neocortical neurons from glutamate-induced excitotoxic injury.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Cells, Cultured; Cytoprotection; Embryo, Mammalian; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine-2-Alanine; Excitatory Amino Acid Agonists; Female; Glutamic Acid; L-Lactate Dehydrogenase; Naltrexone; Narcotic Antagonists; Neocortex; Neurons; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 2000 |
Obstetric and neonatal outcomes associated with maternal naltrexone exposure.
Topics: Adult; Australia; Female; Heroin Dependence; Humans; Infant, Newborn; Naltrexone; Narcotic Antagonists; Portugal; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimesters; United Kingdom | 2001 |
A possible role for implantable naltrexone in the management of the high-risk pregnant heroin user.
Topics: Adult; Dose-Response Relationship, Drug; Drug Implants; Female; Follow-Up Studies; Gestational Age; Heroin Dependence; Humans; Maternal-Fetal Exchange; Naltrexone; Narcotic Antagonists; Patient Compliance; Pregnancy; Pregnancy Outcome; Pregnancy, High-Risk; Substance Withdrawal Syndrome; Treatment Outcome | 2002 |
Behavioral effects of perinatal naltrexone exposure: a preliminary investigation.
Topics: Analgesics; Animals; Animals, Newborn; Behavior, Animal; Conditioning, Operant; Electroshock; Emotions; Female; Morphine; Motor Activity; Naloxone; Naltrexone; Pregnancy; Rats; Reaction Time | 1979 |
Kappa opioid mediation of fetal responses to milk.
Topics: Aging; Animals; Arousal; Chemoreceptor Cells; Dose-Response Relationship, Drug; Female; Fetal Movement; Gestational Age; Morphine; Motor Activity; Naloxone; Naltrexone; Pregnancy; Rats; Receptors, Opioid; Receptors, Opioid, kappa; Sucking Behavior; Taste; Touch | 1992 |
The effect of blockade of kappa-opioid receptors in the medial basal hypothalamus and medial preoptic area on luteinizing hormone release during midpregnancy in the rat.
Topics: Animals; Female; Hypothalamus, Middle; Luteinizing Hormone; Naltrexone; Perfusion; Pregnancy; Pregnancy, Animal; Preoptic Area; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa | 1992 |
Opioids regulate the release of human chorionic gonadotropin hormone from trophoblast tissue.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Benzeneacetamides; Chorionic Gonadotropin; Endorphins; Female; Humans; Morphine; Naltrexone; Placenta; Pregnancy; Pyrrolidines; Receptors, Opioid; Receptors, Opioid, kappa; Trophoblasts | 1991 |
Opioid-dependent behaviors in infant rats: effects of prenatal exposure to ethanol.
Topics: Aging; Analgesia; Animals; Animals, Newborn; Behavior, Animal; Birth Weight; Diet; Ethanol; Female; Morphine; Naltrexone; Nociceptors; Opioid-Related Disorders; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Inbred Strains; Social Isolation; Stress, Psychological; Vocalization, Animal | 1991 |
Perinatal opiate treatment delays growth of cortical dendrites.
Topics: Animals; Animals, Newborn; Dendrites; Female; Male; Morphine; Naltrexone; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Inbred Strains; Receptors, Opioid; Somatosensory Cortex | 1990 |
Naltrexone normalizes the suppression but not the surge of delta 5-3 beta-hydroxysteroid dehydrogenase activity in Leydig cells of stressed rat fetuses.
Topics: 3-Hydroxysteroid Dehydrogenases; Animals; Female; Gestational Age; Leydig Cells; Male; Maternal-Fetal Exchange; Naltrexone; Pregnancy; Rats; Rats, Inbred Strains; Stress, Physiological; Testis; Testosterone | 1990 |
Restricted exposure of mice to primer pheromones coincident with prolactin surges blocks pregnancy by changing hypothalamic dopamine release.
Topics: Animals; Bromocriptine; Dihydroxyphenylalanine; Dopamine; Female; Hypothalamus; Mice; Mice, Inbred BALB C; Mice, Inbred Strains; Naltrexone; Pheromones; Pregnancy; Pregnancy, Animal; Prolactin; Sex Attractants; Time Factors | 1989 |
[Effect of opiate receptor agonists and antagonists on maternal aggression in rats].
Topics: Aggression; Animals; Depression, Chemical; Female; Lactation; Maternal Behavior; Naloxone; Naltrexone; Narcotic Antagonists; Pregnancy; Rats; Receptors, Opioid; Stimulation, Chemical | 1989 |
Kappa opioid receptors of human placental villi modulate acetylcholine release.
Topics: Acetylcholine; Chorionic Villi; Diltiazem; Female; Humans; In Vitro Techniques; Kinetics; Morphine; Naloxone; Naltrexone; Pregnancy; Receptors, Opioid; Receptors, Opioid, kappa | 1989 |
NIDA's Medication Development Program--1989.
Topics: Acquired Immunodeficiency Syndrome; Brain; Cocaine; Drug and Narcotic Control; Female; Heroin Dependence; Humans; Infant, Newborn; Methadone; Methadyl Acetate; Naltrexone; Pregnancy; Psychotropic Drugs; Research Support as Topic; Risk Factors; Substance Abuse, Intravenous; Substance-Related Disorders | 1989 |
Spinal kappa-opiate receptor involvement in the analgesia of pregnancy: effects of intrathecal nor-binaltorphimine, a kappa-selective antagonist.
Topics: Analgesia; Animals; Female; Injections, Spinal; Naltrexone; Pregnancy; Pregnancy, Animal; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, kappa; Sensory Thresholds; Spinal Cord | 1988 |
Opiate antagonism reduces placentophagia and pup cleaning by parturient rats.
Topics: Animals; Drug Tolerance; Feeding Behavior; Female; Labor, Obstetric; Maternal Behavior; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Placenta; Pregnancy; Rats; Rats, Inbred Strains; Receptors, Opioid; Time Factors | 1985 |
Comparison of the oxytocin response to water-deprivation, hyperosmolarity and administration of morphine or naltrexone in lactating and virgin female rats.
Topics: Animals; Female; Lactation; Morphine; Naltrexone; Oxytocin; Pregnancy; Rats; Reference Values; Saline Solution, Hypertonic; Water Deprivation | 1988 |
Prenatal antagonism of stress by naltrexone administration: early and long-lasting effects on emotional behaviors in mice.
Topics: Animals; Arousal; Emotions; Female; Maternal Behavior; Mice; Mice, Inbred Strains; Naltrexone; Pregnancy; Prenatal Exposure Delayed Effects; Vocalization, Animal | 1988 |
Effects of naltrexone in postnatal rats on the recovery of disturbed brain and lymphatic tissues after X-irradiation or ethylnitrosourea treatment in utero.
Topics: Aging; Animals; Body Weight; Brain; Ethylnitrosourea; Female; Male; Naltrexone; Organ Size; Pregnancy; Radiation Injuries, Experimental; Rats; Rats, Inbred Strains | 1987 |
Spinal cord mediation of the opioid analgesia of pregnancy.
Topics: Animals; Electroshock; Endorphins; Female; Gestational Age; Injections, Spinal; Naltrexone; Pain; Pregnancy; Rats; Rats, Inbred Strains; Sensory Thresholds; Spinal Cord | 1987 |
Endogenous analgesia in the pregnant rat: an artifact of weight-dependent measures?
Topics: Animals; Body Weight; Endorphins; Female; Naloxone; Naltrexone; Pain; Postpartum Period; Pregnancy; Pregnancy, Animal; Rats; Rats, Inbred Strains; Sensory Thresholds | 1986 |
Naltrexone blocks the effects of prenatal stress on sexual behavior differentiation in male rats.
Topics: Animals; Endorphins; Female; Male; Maternal-Fetal Exchange; Naltrexone; Pregnancy; Rats; Rats, Inbred Strains; Sex Differentiation; Sexual Behavior, Animal; Stress, Physiological | 1986 |
Ingestion of amniotic fluid enhances opiate analgesia in rats.
Topics: Amniotic Fluid; Analgesia; Animals; Endorphins; Female; Labor, Obstetric; Morphine; Naltrexone; Placenta; Pregnancy; Rats | 1986 |
Placenta ingestion enhances opiate analgesia in rats.
Topics: Analgesia; Animals; Diet; Electroshock; Female; Maternal Behavior; Morphine; Naltrexone; Pain; Placenta; Pregnancy; Rats; Sensory Thresholds | 1985 |